Email this article 
Percutaneous Endoscopic Gastrostomy: Mortality and Risk Factors for Survival
Abstract
Background: The present study evaluated long-term risk factors for survival in patients who have undergone Percutaneous endoscopic Gastrostomy, as well as morbidity and mortality rates.
Methods: The retrospective study included 44 patients who underwent placement of a percutaneous endoscopic gastrostomy tube at various departments at Dicle University Medical Faculty between April 2008-September 2010.
Results: The study evaluated 23 women (52.3%) and 21 men (47.7%), with a median age of 50 20 (17 - 87) years. Median time for Percutaneous endoscopic Gastrostomy placement was 23 8.3 (5 - 45) minutes per patient. Total morbidity was 15.9%, including wound infection (4), tube occlusion (1), peristomal leakage (1), and abdominal wall bleeding (1). Short-term complications were not associated with albumin level (P = 0.312).The median hospital stay was 49.34 60.99 (1 - 314) days. The mean follow-up period was 13.07 13.12 (1 - 41) months. The above-normal level of albumin was found to be effective on survival (P = 0.024). Mortality occurred in 18 (40.9%) patients during the follow-up.
Conclusions: Percutaneous endoscopic Gastrostomy is both safe and effective in that it does not require surgical operation and it can be performed under surface anesthesia. The serum albumin level with patients who have undergone percutaneous endoscopic gastrostomyis an effective factor for survival.
Gastroenterol Res. 2012;5(1):21-27
doi: https://doi.org/10.4021/gr402w
Methods: The retrospective study included 44 patients who underwent placement of a percutaneous endoscopic gastrostomy tube at various departments at Dicle University Medical Faculty between April 2008-September 2010.
Results: The study evaluated 23 women (52.3%) and 21 men (47.7%), with a median age of 50 20 (17 - 87) years. Median time for Percutaneous endoscopic Gastrostomy placement was 23 8.3 (5 - 45) minutes per patient. Total morbidity was 15.9%, including wound infection (4), tube occlusion (1), peristomal leakage (1), and abdominal wall bleeding (1). Short-term complications were not associated with albumin level (P = 0.312).The median hospital stay was 49.34 60.99 (1 - 314) days. The mean follow-up period was 13.07 13.12 (1 - 41) months. The above-normal level of albumin was found to be effective on survival (P = 0.024). Mortality occurred in 18 (40.9%) patients during the follow-up.
Conclusions: Percutaneous endoscopic Gastrostomy is both safe and effective in that it does not require surgical operation and it can be performed under surface anesthesia. The serum albumin level with patients who have undergone percutaneous endoscopic gastrostomyis an effective factor for survival.
Gastroenterol Res. 2012;5(1):21-27
doi: https://doi.org/10.4021/gr402w